Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details)

v3.23.3
STOCKHOLDERS' EQUITY (Details)
 9 Months Ended
Sep. 30, 2023
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Weighted average exercise price, Outstanding ending balance $ 14.25
Common Stock Warrants [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Shares, Outstanding beginning balance | shares 3,017,126
Weighted average exercise price, Outstanding beginning balance $ 11.67
Shares, Granted | shares 4,861,555
Weighted average exercise price, Granted $ 2.35
Shares, Canceled | shares 0
Weighted average exercise price, Canceled $ 0
Shares, Exchanged | shares (1,811,595)
Weighted average exercise price, Exchanged $ 14.25
Shares, Expired | shares 0
Weighted average exercise price, Expired $ 0
Shares, Exercised | shares (307,001)
Weighted average exercise price, Exercised $ 1.75
Shares, Outstanding ending balance | shares 5,760,085
Weighted average exercise price, Outstanding ending balance $ 3.61
Weighted average remaining life in years, Outstanding 4 years 6 months 7 days
Intrinsic value, Outstanding | $ $ 146,442
Shares, Exercisable | shares 5,760,085
Weighted average exercise price, Exercisable $ 3.61
Weighted average remaining life in years, Exercisable 4 years 6 months 7 days
Intrinsic value, Exercisable | $ $ 146,442